Login to Your Account



Transgene Launches €75.7M Push For Pipeline, Manufacturing

By James Etheridge


Wednesday, June 13, 2007

PARIS - Days after announcing that it was to receive an initial milestone payment of €10 million from the Basel, Switzerland-based pharmaceutical company F. Hoffmann-La Roche Ltd., before the end of June, and two months after an up-front payment of €13 million, Transgene SA announced the launch of a €75.7 million (US$101.1 million) capital increase to accelerate the development of its product pipeline and upgrade its manufacturing capabilities. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription